American Century Companies Inc Veracyte, Inc. Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

A detailed history of American Century Companies Inc transactions in Veracyte, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 7,124 shares of VCYT stock, worth $278,334. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,124

Previous 16,116 55.8%

Holding current value

$278,334

Previous $349,000 30.66%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$21.0 - $35.25 $188,832 - $316,968	-8,992 Reduced 55.8%	7,124 $242,000
Q2 2024 Aug 07, 2024	SELL	$18.86 - $23.55 $188,128 - $234,911	-9,975 Reduced 38.23%	16,116 $349,000
Q1 2024 May 14, 2024	BUY	$21.0 - $29.1 $175,980 - $243,858	8,380 Added 47.32%	26,091 $578,000
Q4 2023 Feb 13, 2024	BUY	$19.72 - $28.68 $349,260 - $507,951	17,711 New	17,711 $487,000
Q3 2023 Nov 13, 2023	SELL	$22.33 - $29.92 $117,455 - $157,379	-5,260 Reduced 22.9%	17,711 $395,000
Q2 2023 Aug 14, 2023	BUY	$20.96 - $26.99 $251,037 - $323,259	11,977 Added 108.94%	22,971 $585,000
Q1 2023 May 11, 2023	BUY	$20.58 - $27.89 $26,465 - $35,866	1,286 Added 13.25%	10,994 $245,000
Q4 2022 Feb 13, 2023	BUY	$15.31 - $29.94 $148,629 - $290,657	9,708 New	9,708 $230,000
Q2 2021 Aug 05, 2021	SELL	$32.94 - $56.62 $281,538 - $483,931	-8,547 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$44.47 - $81.38 $3,201 - $5,859	72 Added 0.85%	8,547 $459,000
Q4 2020 Feb 12, 2021	SELL	$32.49 - $61.88 $112,577 - $214,414	-3,465 Reduced 29.02%	8,475 $415,000
Q3 2020 Nov 13, 2020	BUY	$26.73 - $35.67 $28,146 - $37,560	1,053 Added 9.67%	11,940 $388,000
Q2 2020 Aug 13, 2020	SELL	$19.49 - $28.11 $395,627 - $570,604	-20,299 Reduced 65.09%	10,887 $282,000
Q1 2020 May 14, 2020	SELL	$16.13 - $30.17 $272,935 - $510,506	-16,921 Reduced 35.17%	31,186 $758,000
Q4 2019 Feb 12, 2020	SELL	$20.78 - $29.99 $1.37 Million - $1.98 Million	-65,950 Reduced 57.82%	48,107 $1.34 Million
Q3 2019 Nov 13, 2019	BUY	$23.87 - $30.93 $271,998 - $352,447	11,395 Added 11.1%	114,057 $2.74 Million
Q2 2019 Aug 14, 2019	SELL	$22.1 - $28.56 $968,598 - $1.25 Million	-43,828 Reduced 29.92%	102,662 $2.93 Million
Q1 2019 May 14, 2019	BUY	$12.0 - $25.76 $507,780 - $1.09 Million	42,315 Added 40.62%	146,490 $0
Q4 2018 Feb 13, 2019	BUY	$9.15 - $14.85 $953,201 - $1.55 Million	104,175 New	104,175 $1.31 Million

Others Institutions Holding VCYT

# of Institutions

307

Shares Held

81.7M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.8B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Veracyte, Inc. Transaction History